## Management of Heart Failure in Down Syndrome with VSD ### Background Children with Down syndrome have a significantly increased incidence of congenital heart defects, with VSD being the most common (30–40% of cardiac lesions in trisomy 21). When these defects result in left-to-right shunting and volume overload, heart failure develops early in infancy. ### Why Enalapril is the Drug of Choice **Key Point:** ACE inhibitors (particularly enalapril) are the first-line vasodilators for pediatric heart failure management in Down syndrome and other congenital cardiac conditions. **High-Yield:** Enalapril works by: 1. Reducing afterload via systemic vasodilation 2. Decreasing preload through mild diuretic effect 3. Preventing ventricular remodeling via neurohormonal blockade 4. Improving coronary perfusion pressure ### Mechanism in VSD Context In a large VSD with left-to-right shunting, the left ventricle faces volume overload. Enalapril reduces systemic vascular resistance, thereby: - Decreasing the pressure gradient across the defect - Reducing the shunt fraction - Improving forward cardiac output - Reducing pulmonary congestion ### Dosing in Infants Enalapril is dosed at 0.1 mg/kg/dose, twice daily (maximum 5 mg/day initially), titrated based on response and renal function. ### Typical Heart Failure Regimen in Down Syndrome | Drug Class | Agent | Role | |---|---|---| | Diuretic | Furosemide | Reduce pulmonary edema, preload | | Inotrope (acute) | Digoxin | Improve contractility, slow AV conduction | | Vasodilator (first-line) | **Enalapril** | **Reduce afterload, prevent remodeling** | | Beta-blocker (chronic) | Carvedilol | Add later for neurohormonal blockade | **Clinical Pearl:** In Down syndrome, cardiac defects often require early surgical intervention (repair or palliation). Medical management with ACE inhibitors bridges the infant until surgery and reduces perioperative risk.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.